Gregory S H, Sagnimeni A J, Wing E J
Department of Medicine, University of Pittsburgh Medical Center, Pennsylvania, USA.
Infect Immun. 1996 Oct;64(10):3983-6. doi: 10.1128/iai.64.10.3983-3986.1996.
Listeria monocytogenes injected intravenously into mice is taken up in the liver, where hepatocytes serve as the principal site of intracellular replication. The factors effecting entry of L. monocytogenes into hepatic cells remain to be determined. Others have shown that the protein products of the inlAB (internalin) operon are required for maximum entry of L. monocytogenes into a number of cell lines in vitro. Likewise, we report here that expression of the inlAB operon was required for maximum uptake of L. monocytogenes by primary cultures of mouse hepatocytes. Uptake of an inlAB mutant strain of L. monocytogenes was approximately 10-fold less than that of the isogenic wild-type control. In contrast, inlAB expression was not a factor in (i) clearance of L. monocytogenes injected intravenously into mice and taken up in the liver, (ii) the distribution of L. monocytogenes among hepatocytes and nonparenchymal cells in the liver, or (iii) internalization of L. monocytogenes by hepatic cells in vivo. These latter findings suggest that infection of hepatic cells by L. monocytogenes in vivo does not require the protein products of the inlAB operon.
静脉注射到小鼠体内的单核细胞增生李斯特菌会在肝脏中被摄取,肝细胞是其细胞内复制的主要部位。影响单核细胞增生李斯特菌进入肝细胞的因素尚待确定。其他人已经表明,inlAB(内化素)操纵子的蛋白质产物是单核细胞增生李斯特菌在体外最大程度进入多种细胞系所必需的。同样,我们在此报告,inlAB操纵子的表达是小鼠肝细胞原代培养物最大程度摄取单核细胞增生李斯特菌所必需的。单核细胞增生李斯特菌inlAB突变株的摄取量比同基因野生型对照少约10倍。相比之下,inlAB表达不是以下方面的因素:(i)静脉注射到小鼠体内并在肝脏中摄取的单核细胞增生李斯特菌的清除,(ii)单核细胞增生李斯特菌在肝脏中的肝细胞和非实质细胞之间的分布,或(iii)体内肝细胞对单核细胞增生李斯特菌的内化。这些最新发现表明,体内单核细胞增生李斯特菌对肝细胞的感染不需要inlAB操纵子的蛋白质产物。